ProShare Advisors’s Merck MRK Stock Holding History

ProShare Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.2M	Sell	525,295 -103,580	-16%	-$12M	0.09%	149
2025 Q4	$66.2M	Buy	628,875 +45,109	+8%	+$4.23M	0.12%	164
2025 Q3	$49M	Sell	583,766 -27,967	-5%	-$2.3M	0.1%	163
2025 Q2	$48.4M	Buy	611,733 +37,005	+6%	+$2.94M	0.1%	173
2025 Q1	$51.6M	Sell	574,728 -16,339	-3%	-$1.53M	0.12%	162
2024 Q4	$58.8M	Buy	591,067 +89,745	+18%	+$9.25M	0.13%	144
2024 Q3	$56.9M	Sell	501,322 -20,331	-4%	-$2.42M	0.14%	137
2024 Q2	$64.6M	Buy	521,653 +34,574	+7%	+$4.45M	0.17%	124
2024 Q1	$64.3M	Sell	487,079 -43,822	-8%	-$5.4M	0.17%	130
2023 Q4	$57.9M	Sell	530,901 -36,530	-6%	-$3.79M	0.18%	121
2023 Q3	$58.4M	Sell	567,431 -35,302	-6%	-$3.8M	0.18%	122
2023 Q2	$69.5M	Sell	602,733 -8,106	-1%	-$920K	0.2%	111
2023 Q1	$65M	Buy	610,839 +62,941	+11%	+$6.8M	0.2%	111
2022 Q4	$60.8M	Buy	547,898 +18,198	+3%	+$1.86M	0.21%	104
2022 Q3	$45.6M	Sell	529,700 -35,416	-6%	-$3.16M	0.18%	115
2022 Q2	$51.5M	Sell	565,116 -218,960	-28%	-$19.4M	0.17%	124
2022 Q1	$64.3M	Sell	784,076 -34,725	-4%	-$2.74M	0.14%	152
2021 Q4	$62.8M	Buy	818,801 +186,485	+29%	+$14.9M	0.12%	164
2021 Q3	$47.5M	Sell	632,316 -22,451	-3%	-$1.71M	0.13%	155
2021 Q2	$50.9M	Buy	654,767 +54,956	+9%	+$4.09M	0.15%	138
2021 Q1	$44.1M	Buy	599,811 +58,394	+11%	+$4.31M	0.14%	154
2020 Q4	$42.3M	Buy	541,417 +1,079	+0.2%	+$82.5K	0.16%	139
2020 Q3	$42.8M	Sell	540,338 -55,436	-9%	-$4.34M	0.2%	118
2020 Q2	$44M	Buy	595,774 +101,193	+20%	+$7.62M	0.23%	110
2020 Q1	$36.3M	Sell	494,581 -211,729	-30%	-$16.6M	0.26%	98
2019 Q4	$61.3M	Buy	706,310 +122,524	+21%	+$10.1M	0.28%	93
2019 Q3	$46.9M	Buy	583,786 +48,500	+9%	+$3.89M	0.26%	94
2019 Q2	$42.8M	Sell	535,286 -114,120	-18%	-$8.74M	0.26%	97
2019 Q1	$51.5M	Buy	649,406 +12,471	+2%	+$933K	0.31%	96
2018 Q4	$46.4M	Buy	636,935 +105,608	+20%	+$7.46M	0.33%	88
2018 Q3	$36M	Sell	531,327 -137,424	-21%	-$8.76M	0.24%	98
2018 Q2	$38.7M	Sell	668,751 -95,373	-12%	-$5.38M	0.26%	99
2018 Q1	$39.7M	Buy	764,124 +45,943	+6%	+$2.48M	0.26%	104
2017 Q4	$38.6M	Buy	718,181 +263,216	+58%	+$14.6M	0.27%	99
2017 Q3	$27.8M	Buy	454,965 +53,926	+13%	+$3.27M	0.26%	95
2017 Q2	$24.5M	Sell	401,039 -44,038	-10%	-$2.68M	0.24%	92
2017 Q1	$27M	Sell	445,077 -4,017	-0.9%	-$244K	0.28%	87
2016 Q4	$25.2M	Buy	449,094 +101,761	+29%	+$5.96M	0.28%	86
2016 Q3	$20.7M	Sell	347,333 -135,738	-28%	-$7.94M	0.29%	83
2016 Q2	$26.6M	Sell	483,071 -21,155	-4%	-$1.13M	0.34%	83
2016 Q1	$25.5M	Sell	504,226 -187,645	-27%	-$9.19M	0.35%	87
2015 Q4	$34.9M	Buy	691,871 +12,241	+2%	+$617K	0.42%	49
2015 Q3	$32M	Buy	679,630 +35,301	+5%	+$1.88M	0.45%	44
2015 Q2	$35M	Sell	644,329 -119,830	-16%	-$6.72M	0.48%	38
2015 Q1	$41.9M	Sell	764,159 -59,992	-7%	-$3.4M	0.49%	34
2014 Q4	$44.7M	Buy	824,151 +154,605	+23%	+$8.61M	0.52%	32
2014 Q3	$37.9M	Sell	669,546 -59,192	-8%	-$3.32M	0.5%	30
2014 Q2	$40.2M	Sell	728,738 -35,192	-5%	-$1.92M	0.52%	29
2014 Q1	$41.4M	Buy	763,930 +42,818	+6%	+$2.22M	0.52%	28
2013 Q4	$34.4M	Buy	721,112 +323,504	+81%	+$14.8M	0.51%	31
2013 Q3	$18.1M	Sell	397,608 -243,127	-38%	-$11.1M	0.43%	31
2013 Q2	$28.4M	Buy	+640,735	New	+$28.6M	0.56%	28

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ProShare Advisors's MRK Position: Q1 2026 in Review

ProShare Advisors reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $12M and leaving 525,295 shares worth $63.2M. The position accounts for 0.09% of the portfolio, ranked #149.

ProShare Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $69.5M in Q2 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

ProShare Advisors held 525,295 shares of Merck worth $63.2M as of Q1 2026.
ProShare Advisors sold 103,580 Merck shares in Q1 2026, an estimated $12M.
Merck made up 0.09% of ProShare Advisors's portfolio in Q1 2026, its #149 holding.
ProShare Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
ProShare Advisors's Merck position peaked at $69.5M in Q2 2023.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.